Shunt device startup wants to break barriers in nitinol and heart sensing

Adona Medical is designing its adjustable heart shunt device with pressure sensors on both sides of the heart. [Illustration courtesy of Adona Medical]

Medical devices have yet to tap nitinol’s shape memory properties, but that’s just one breakthrough Adona Medical hopes to achieve with its adjustable, bi-atrial-sensing heart shunt.

Adona Medical co-founder and CEO Brian Fahey’s presentation on his shunt device startup’s aspirations elicited palpable interest from the cardiologists in the room at CSI Frankfurt.

“You plan to disrupt two fields in heart failure?” asked Dr. Daniel Burkhoff, the director of heart failure, hemodynamics and MCS research at the Cardiovascular Research Foundation’s Clinical Trials Center.

“We’re going to try,” Fahey replied. “Our plan is to improve patient care.”

Fahey has publicly said little abo…

Read more
  • 0

Shifamed’s Adona Medical unveils next-gen heart failure management platform

Shifamed portfolio company Adona Medical today announced the introduction of its next-generation heart failure platform.

Brian Fahey, Adona Medical co-founder and CEO, unveiled the platform at the CSI Frankfurt 2023 conference. There, Fahey introduced the developing interatrial shunt technology in a presentation.

The Adona heart failure management platform features an adjustable interatrial shunt with integrated bi-atrial pressure monitoring. Its shunt flow channel offers an adaptable geometry capable of growing larger or minimizing at any time post-implant. This can help optimize shunting flow or dose for patient needs at the time of the initial procedure. It then can adjust as the patient’s condition evolves over time.

Integrated sensors included in the platform capture pressure readings from both the left and right atria multiple times per day. These sensors don’t require patient interaction, Adona says. Daily readings from the sensors hel…

Read more
  • 0

Adona Medical raises $20.5M

Shifamed portfolio company Adona Medical filed an SEC Form D to confirm the sale of nearly $20.5 million in equity.

Campbell, Calif.-based Adona Medical is offering more than $24.8 million in equity in a new notice that had its first sale on Aug. 20, 2020. Adona Medical does not intend for the offering to last longer than one year, according to the filing.

The minimum investment accepted in the equity offering was $1, and so far 45 investors have contributed to the $20.5 million total, with nearly $4.4 million remaining for the company to sell.

No use of proceeds was listed for the offering, while the company confirmed that it is not being made in connection with a business combination transaction, such as a merger, acquisition or exchange offer.

Adona Medical was formed less than one year ago in December 2019 and develops interventional approaches for treating heart failure, according to the company.

Read more
  • 0